Approvals/TGA/HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector

Approved

STANDARD

HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector

Samsung Bioepis AU Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ae4cba4dcf837f0e
Product Name: HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector
Artg Id: 284248
Artg Name: HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector
Sponsor: Samsung Bioepis AU Pty Ltd
Company Detail Path: /organization/samsung-bioepis-au-pty-ltd
Artg Date: 2018-01-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01179-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01180-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ae4cba4dcf837f0e

Type

Standard